Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_assertion description "[Potentially druggable kinase fusions involving ALK, ROS, RET, NTRK and FGFR gene families were detected in bladder carcinoma (3.3%), glioblastoma (4.4%), head and neck cancer (1.0%), low-grade glioma (1.5%), lung adenocarcinoma (1.6%), lung squamous cell carcinoma (2.3%) and thyroid carcinoma (8.7%), suggesting a potential for application of kinase inhibitors across tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_assertion evidence source_evidence_literature NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_assertion SIO_000772 25500544 NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_assertion wasDerivedFrom befree-2016 NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_assertion wasGeneratedBy ECO_0000203 NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.
- befree-2016 importedOn "2016-02-19" NP1247368.RAa4mYYWaQfLARXEOxCRC8K7k9rq8nTmcP2Kc2YeO_150130_provenance.